Table 3.
Haematological parameters after oral administration of P. copri for 29 days.
| Blood cell parameter | Control | Pasteurized | Live |
|---|---|---|---|
| WBC (109/L) | 4.098 ± 0.596 | 4.497 ± 0.494 | 4.880 ± 0.666 |
| LYM (109/L) | 3.301 ± 0,543 | 3.762 ± 0.410 | 4.373 ± 0.603 |
| MON (109/L) | 0.313 ± 0.080 | 0.330 ± 0.067 | 0.294 ± 0.063 |
| NEU (109/L) | 0.483 ± 0.127 | 0.403 ± 0.091 | 0.214 ± 0.073 |
| MCH (pg) | 14.280 ± 0.315 | 14.250 ± 0.119 | 14.480 ± 0.111 |
| MCHC (g/dL) | 32.500 ± 0.764 | 33.510 ± 0.254 | 33.410 ± 0.206 |
| RDWs (fl) | 33.290 ± 0.522 | 32.040 ± 0.302 | 32.590 ± 0.502 |
| RDWc % (%) | 17.420 ± 0.214 | 17.370 ± 0.157 | 17.360 ± 0.200 |
| PLT (109/L) | 429.100 ± 26.429 | 447.900 ± 57.510 | 486.800 ± 40.908 |
| PCT % (%) | 0.233 ± 0.016 | 0.245 ± 0.033 | 0.263 ± 0.022 |
| MPV (fl) | 5.450 ± 0.083 | 5.460 ± 0.070 | 5.390 ± 0.069 |
| PDWs (fl) | 5.650 ± 0.099 | 5.830 ± 0.176 | 5.820 ± 0.184 |
| PDWc % (%) | 27.800 ± 0.257 | 28.230 ± 0.404 | 28.180 ± 0.419 |
Values are presented as mean ± SEM (n = 10).
No mean values were significantly different from the control group (p < 0.05).
WBC white blood cell count, LYM lymphocytes, MON monocytes, NEU neutrophils, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, RDWs red cell distribution width—SD, RDWc red cell distribution width—CV, PLT platelet count, PCT thrombocrit, MPV mean platelet volume, PDWs platelet distribution width—SV, PDWc platelet distribution width—CV.